Monetary Management Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$806K Hold
9,300
0.19% 112
2025
Q4
$893K Sell
9,300
-1,375
-13% -$134K 0.21% 99
2025
Q3
$1.02M Hold
10,675
0.23% 87
2025
Q2
$931K Hold
10,675
0.23% 94
2025
Q1
$959K Hold
10,675
0.26% 86
2024
Q4
$853K Sell
10,675
-250
-2% -$21.6K 0.22% 91
2024
Q3
$984K Sell
10,925
-275
-2% -$23.1K 0.25% 86
2024
Q2
$882K Sell
11,200
-1,382
-11% -$113K 0.23% 90
2024
Q1
$1.1M Sell
12,582
-218
-2% -$18.6K 0.31% 82
2023
Q4
$1.05M Buy
12,800
+75
+0.6% +$5.72K 0.33% 77
2023
Q3
$997K Sell
12,725
-450
-3% -$37.7K 0.33% 72
2023
Q2
$1.16M Sell
13,175
-775
-6% -$66.7K 0.36% 72
2023
Q1
$1.12M Sell
13,950
-817
-6% -$66.6K 0.33% 76
2022
Q4
$1.15M Sell
14,767
-725
-5% -$58.8K 0.36% 74
2022
Q3
$1.25M Buy
15,492
+1,250
+9% +$112K 0.41% 62
2022
Q2
$1.28M Sell
14,242
-125
-0.9% -$12.7K 0.4% 63
2022
Q1
$1.59M Sell
14,367
-979
-6% -$103K 0.42% 60
2021
Q4
$1.59M Buy
15,346
+1,375
+10% +$159K 0.39% 61
2021
Q3
$1.75M Buy
13,971
+450
+3% +$58.2K 0.48% 51
2021
Q2
$1.68M Sell
13,521
-55
-0.4% -$6.91K 0.51% 48
2021
Q1
$1.6M Hold
13,576
0.5% 52
2020
Q4
$1.59M Buy
13,576
+250
+2% +$27.5K 0.52% 53
2020
Q3
$1.39M Buy
13,326
+650
+5% +$65.3K 0.49% 55
2020
Q2
$1.16M Buy
12,676
+3,725
+42% +$357K 0.44% 61
2020
Q1
$807K Sell
8,951
-250
-3% -$26.6K 0.36% 71
2019
Q4
$1.04M Sell
9,201
-116
-1% -$12.7K 0.38% 71
2019
Q3
$1.01M Sell
9,317
-100
-1% -$10.4K 0.38% 74
2019
Q2
$917K Hold
9,417
0.35% 84
2019
Q1
$858K Hold
9,417
0.34% 83
2018
Q4
$857K Hold
9,417
0.39% 75
2018
Q3
$926K Sell
9,417
-400
-4% -$37K 0.35% 73
2018
Q2
$840K Hold
9,817
0.34% 76
2018
Q1
$788K Hold
9,817
0.33% 75
2017
Q4
$793K Hold
9,817
0.32% 72
2017
Q3
$763K Sell
9,817
-1,900
-16% -$158K 0.32% 71
2017
Q2
$1.04M Sell
11,717
-250
-2% -$21.1K 0.43% 69
2017
Q1
$964K Sell
11,967
-395
-3% -$30.9K 0.42% 68
2016
Q4
$881K Sell
12,362
-1,250
-9% -$98.2K 0.41% 67
2016
Q3
$1.18M Sell
13,612
-100
-0.7% -$8.71K 0.54% 60
2016
Q2
$1.19M Sell
13,712
-369
-3% -$29.8K 0.55% 61
2016
Q1
$1.06M Sell
14,081
-1,350
-9% -$102K 0.51% 63
2015
Q4
$1.19M Sell
15,431
-1,500
-9% -$113K 0.57% 59
2015
Q3
$1.13M Sell
16,931
-800
-5% -$58.9K 0.57% 56
2015
Q2
$1.31M Hold
17,731
0.59% 54
2015
Q1
$1.38M Buy
17,731
+19
+0.1% +$1.44K 0.61% 54
2014
Q4
$1.28M Sell
17,712
-1,555
-8% -$108K 0.57% 59
2014
Q3
$1.19M Buy
19,267
+1,558
+9% +$99.1K 0.55% 55
2014
Q2
$1.13M Buy
17,709
+400
+2% +$24.3K 0.53% 61
2014
Q1
$1.06M Sell
17,309
-1,000
-5% -$58.3K 0.5% 65
2013
Q4
$1.05M Hold
18,309
0.49% 64
2013
Q3
$975K Buy
18,309
+1,600
+10% +$86.1K 0.51% 63
2013
Q2
$860K Buy
+16,709
New +$826K 0.47% 69

Other funds holding MDT

Monetary Management Group's MDT Position: Q1 2026 in Review

Monetary Management Group held its Medtronic (MDT) position steady in Q1 2026 at 9,300 shares worth $806K. The position accounts for 0.19% of the portfolio, ranked #112.

Monetary Management Group first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.75M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Monetary Management Group held 9,300 shares of Medtronic worth $806K as of Q1 2026.
  • Monetary Management Group left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.19% of Monetary Management Group's portfolio in Q1 2026, its #112 holding.
  • Monetary Management Group first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Monetary Management Group's Medtronic position peaked at $1.75M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Monetary Management Group's 13F filing for Q1 2026, filed 13 May 2026.